Skip to Main content Skip to Navigation
Journal articles

Retreatment with sofosbuvir plus grazoprevir plus elbasvir plus ribavirin of patients with Hepatitis C virus Genotype 1 or 4 with RASs at failure of a sofosbuvir plus ledipasvir or plus daclatasvir or plus simeprevir regimen (ANRS HC34 REVENGE study)

Abstract : 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) - Boston, MA - 2016-11-11
Document type :
Journal articles
Complete list of metadatas

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01487921
Contributor : Laurent Jonchère <>
Submitted on : Monday, March 13, 2017 - 11:27:21 AM
Last modification on : Wednesday, October 14, 2020 - 3:57:22 AM

Identifiers

  • HAL Id : hal-01487921, version 1

Citation

Victor Ledinghen, Claire Laforest, Christophe Hézode, Stanislas Pol, Alain Renault, et al.. Retreatment with sofosbuvir plus grazoprevir plus elbasvir plus ribavirin of patients with Hepatitis C virus Genotype 1 or 4 with RASs at failure of a sofosbuvir plus ledipasvir or plus daclatasvir or plus simeprevir regimen (ANRS HC34 REVENGE study). Hepatology, Wiley-Blackwell, 2017, 64 (6), pp.1130A--1130A. ⟨hal-01487921⟩

Share

Metrics

Record views

299